STOCK TITAN

Lifeway Foods® Announces Record-Breaking Results for the First Quarter Ended March 31, 2026

Rhea-AI Impact
(High)
Rhea-AI Sentiment
(Positive)
Tags

Lifeway Foods (Nasdaq:LWAY) reported record Q1 2026 results. Net sales reached $63.0 million, up 36.7% year-over-year, marking the 26th consecutive quarter of growth. Gross margin rose to 27.5%, up 360 bps, and net income increased 32% to $4.7 million.

SG&A was $10.9 million, up 16.8%, reflecting higher marketing and brand investments. Lifeway highlighted growth in Kefir and Farmer Cheese, new products like Muscle Mates and Kefir Butter, and reiterated its $45–$50 million Adjusted EBITDA target for FY 2027.

Loading...
Loading translation...

AI-generated analysis. Not financial advice.

Positive

  • Net sales $63.0 million, up 36.7% year-over-year
  • Gross margin 27.5%, expanding 360 basis points year-over-year
  • Net income $4.7 million, up 32% versus prior year
  • SG&A leveraged by 300 basis points despite higher spend
  • 26th consecutive quarter of year-over-year net sales growth
  • Reiterated $45–$50 million Adjusted EBITDA target for FY 2027

Negative

  • Selling, general and administrative expenses rose 16.8% year-over-year to $10.9 million

News Market Reaction – LWAY

-4.59% 4.8x vol
5 alerts
-4.59% News Effect
-26.0% Trough in 38 min
-$20M Valuation Impact
$416.43M Market Cap
4.8x Rel. Volume

On the day this news was published, LWAY declined 4.59%, reflecting a moderate negative market reaction. Argus tracked a trough of -26.0% from its starting point during tracking. Our momentum scanner triggered 5 alerts that day, indicating moderate trading interest and price volatility. This price movement removed approximately $20M from the company's valuation, bringing the market cap to $416.43M at that time. Trading volume was very high at 4.8x the daily average, suggesting heavy selling pressure.

Data tracked by StockTitan Argus on the day of publication.

Key Figures

Q1 2026 Net Sales: $63.0M Net Sales Growth: 36.7% YoY Gross Profit Margin: 27.5% +5 more
8 metrics
Q1 2026 Net Sales $63.0M First quarter 2026 net sales, record and above prior guidance range
Net Sales Growth 36.7% YoY Year-over-year net sales increase for Q1 2026
Gross Profit Margin 27.5% Q1 2026 gross margin, up from 23.9% last year
Gross Margin Expansion 360 basis points Year-over-year Q1 2026 gross margin improvement
SG&A Expenses $10.9M Q1 2026 SG&A, up 16.8% year-over-year
Net Income $4.7M Q1 2026 net income vs $3.5M prior-year quarter
EPS (Basic) $0.31 Q1 2026 basic EPS vs $0.23 prior-year
FY2027 Adj. EBITDA Target $45–$50M Reiterated long-term Adjusted EBITDA target for FY 2027

Market Reality Check

Price: $23.60 Vol: Volume 94,089 is 1.71x th...
high vol
$23.60 Last Close
Volume Volume 94,089 is 1.71x the 20-day average of 54,910, showing elevated trading interest pre‑news. high
Technical Price at $27.25 is trading above the 200-day MA of $24.76 and about mid-range between the 52-week low $17.31 and high $34.20.

Peers on Argus

LWAY gained 7.45% while key peers were mixed: WEST -2.78%, SENEA -1.52%, USNA +2...

LWAY gained 7.45% while key peers were mixed: WEST -2.78%, SENEA -1.52%, USNA +2.62%, MAMA +2.24%, OTLY +0.50%. The move appears stock-specific rather than sector-driven.

Previous Earnings Reports

5 past events · Latest: Mar 17 (Positive)
Same Type Pattern 5 events
Date Event Sentiment Move Catalyst
Mar 17 Full-year 2025 earnings Positive -7.2% Record 2025 net sales $212.5M, 13.7% growth and 54% net income increase.
May 13 Q1 2025 earnings Positive -8.2% Q1 2025 net sales $46.1M, 3.3% growth and 44% EPS increase.
Mar 24 Record 2024 earnings Neutral +2.2% Record full-year 2024 earnings combined with board nomination dispute disclosure.
Mar 14 Full-year 2024 earnings Positive -1.8% Record 2024 net sales $186.8M with 17% growth and strong margins.
Nov 14 Q3 2024 earnings Positive -4.3% Q3 2024 net sales $46.1M, 12.7% growth and improved gross margin.
Pattern Detected

Earnings releases have generally been positive fundamentally but often saw negative next-day moves, suggesting a pattern of sell-the-news reactions that contrasts with today’s positive move.

Recent Company History

Recent history shows Lifeway repeatedly posting record or strong results. In 2024 and 2025, the company reported record full-year earnings and over 20 consecutive quarters of growth, with net sales of $186.8M in 2024 and $212.5M in 2025. Prior earnings headlines consistently highlighted margin expansion and net income growth, yet shares often fell the next day. Today’s Q1 2026 record quarter and strong growth build directly on that trend of operational momentum.

Historical Comparison

-3.8% avg move · Past earnings headlines for LWAY saw an average move of about -3.83%. Today’s +7.45% reaction to ano...
earnings
-3.8%
Average Historical Move earnings

Past earnings headlines for LWAY saw an average move of about -3.83%. Today’s +7.45% reaction to another record quarter stands out versus that pattern.

Earnings releases show a progression from record full-year 2024 results to even higher record 2025 sales, followed by strong, accelerating growth into Q1 2026 with expanding margins and continued Adjusted EBITDA targets for FY2027.

Regulatory & Risk Context

Active S-3 Shelf
Shelf Active
Active S-3 Shelf Registration 2025-10-29

An effective shelf registration filed on Oct 29, 2025 covers up to 3,454,756 resale shares for Danone North America PBC and affiliates. The company states it will not receive proceeds from these secondary sales but will bear certain registration expenses, enabling the selling stockholder to sell shares more flexibly.

Market Pulse Summary

This announcement highlights Lifeway’s record Q1 2026 performance, with net sales of $63.0M, 36.7% g...
Analysis

This announcement highlights Lifeway’s record Q1 2026 performance, with net sales of $63.0M, 36.7% growth, and gross margin expanding to 27.5%. It extends a multi-year run of record results and reiterates a FY 2027 Adjusted EBITDA target of $45–$50M. Investors may track whether volume-led growth, margin gains, and product innovation progress at a pace consistent with prior full-year 2024 and 2025 milestones.

Key Terms

gross profit margin, basis points, selling, general and administrative expenses, Adjusted EBITDA, +3 more
7 terms
gross profit margin financial
"Significant gross profit margin expansion of 360 basis points and net income growth of 32%"
Gross profit margin shows how much money a company keeps from sales after paying for the goods or services it sold. It’s like checking how much profit is left over from each dollar earned before covering other costs. A higher margin indicates the company makes more money from its sales, which helps assess its profitability and efficiency.
basis points financial
"Significant gross profit margin expansion of 360 basis points and net income growth"
Basis points are a way to measure small changes in interest rates or percentages, where one basis point equals 0.01%. For example, if a loan's interest rate increases by 50 basis points, it's gone up by 0.50%. They help people understand tiny differences in rates that can add up over time, making financial comparisons clearer.
selling, general and administrative expenses financial
"Selling, general and administrative expenses were $10.9 million, up 16.8% from last year"
Selling, general and administrative expenses are the costs a business incurs to operate daily, such as sales efforts, office management, and administrative tasks. These expenses are important to investors because they impact the company’s profitability; higher costs can reduce profits, while efficient management of these expenses can indicate better financial health.
Adjusted EBITDA financial
"The Company reiterated its long-term target of $45–$50 million in Adjusted EBITDA1 for FY 2027"
Adjusted EBITDA is a way companies measure how much money they make from their core operations, like running a business, by removing certain costs or income that aren’t part of regular business activities. It helps investors see how well a company is doing without distractions from unusual expenses or gains, making it easier to compare companies or track performance over time.
non-GAAP financial measure financial
"Adjusted EBITDA is a non-GAAP financial measure."
A non-GAAP financial measure is a way companies present their financial results that excludes certain expenses or income to show how they believe their core business is performing. It matters because it can give a clearer picture of how the company is really doing, but it can also be used to make results look better than they actually are.
stock-based compensation financial
"plus Depreciation and Amortization, plus Stock-Based Compensation."
Stock-based compensation is when a company pays employees, directors or consultants with shares or the right to buy shares instead of or in addition to cash. It matters to investors because issuing stock or options spreads ownership thinner (like cutting a pie into more slices), which can reduce each existing share’s claim on profits and can also change reported earnings; investors watch it to assess true cost of running the business and how management is incentivized.
GLP-1 medical
"demand from GLP-1 users seeking nutrient-dense, probiotic foods is particularly strong."
GLP-1 (glucagon-like peptide-1) is a natural hormone in the body that helps regulate blood sugar levels and appetite. Its significance to investors lies in its role as the basis for a class of medications that address conditions like type 2 diabetes and obesity, which are large and growing markets. Advances or investments in GLP-1-based treatments can signal opportunities in healthcare innovation and potentially impact pharmaceutical companies’ growth.

AI-generated analysis. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

Achieves $63.0 million in net sales, a 37% volume-led net sales increase, driven by the Company's flagship Lifeway Kefir

Record-breaking results signal robust Kefir & Farmer Cheese growth, supported by the widening consumer focus on protein-rich, probiotic foods

Significant gross profit margin expansion of 360 basis points and net income growth of 32% reflect the Company's disciplined operational execution

MORTON GROVE, Ill., May 14, 2026 /PRNewswire/ -- Lifeway Foods, Inc. (Nasdaq: LWAY) ("Lifeway" or "the Company"), the leading U.S. supplier of kefir and fermented probiotic foods, today announced financial results for the first quarter ended March 31, 2026.

"We kicked off 2026 with a blowout quarter that demonstrates the extraordinary momentum we've built across our business," said Julie Smolyansky, President and Chief Executive Officer of Lifeway Foods. "We far exceeded our previous record with net sales of $63.0 million, up 37% year-over-year, surpassing sixty million in quarterly net sales for the first time and marking our 26th consecutive quarter of year-over-year growth. This exceptional top-line performance was accompanied by sizeable gross margin expansion of 360 basis points year-over-year, and equally strong net income growth of 32% that reflects a clean flow-through from our significant sales growth down to the bottom line. We are investing meaningfully behind our core products to support our rapid growth, and we continue to see impressive velocity acceleration. We also leveraged our SG&A by 300 basis points this quarter, demonstrating the increasing return and effectiveness of our investments."

Ms. Smolyansky continued, "We believe Lifeway is uniquely positioned at the intersection of numerous consumer tailwinds with our on-trend, functional product offerings. The consumer focus on health and wellness continues to increase, gut-health awareness is spreading and demand from GLP-1 users seeking nutrient-dense, probiotic foods is particularly strong. We address each of these trends with our flagship Lifeway Kefir and high-protein Lifeway Farmer Cheese, while continuing to build a pipeline of innovative products, including Muscle Mates™ with creatine and probiotic Kefir Butter™. Together, these offerings bring new excitement to the category and expand our reach across the cultured dairy landscape. We are very excited about our trajectory and confident in our ability to execute throughout 2026 as we further capitalize on the growing consumer demand in our space."

First Quarter 2026 Highlights

  • Net Sales: $63.0 million, up 36.7% year-over-year.
  • Gross Profit Margin: 27.5%, up 360 basis points from 23.9% last year.
  • Selling, general and administrative expenses were $10.9 million, up 16.8% from last year, reflecting continued investment in marketing and brand awareness.
  • Net Income: $4.7 million, or $0.31 per basic and $0.30 per diluted common share, compared to a net income of $3.5 million, or $0.23 per basic and diluted common share in the prior year.

Expanding Lifeway Visibility

Lifeway recently announced strategic partnerships, experiential marketing initiatives, and product innovation designed to elevate the brand's visibility and engage health-conscious consumers nationwide.

  • The Company partnered with Erewhon to launch the Tropical Lifeway Smoothie, made with Organic Lifeway Kefir, offering the ultimate summer refreshment reminiscent of a creamy frozen lemonade while delivering the added benefits of probiotics and protein.
  • The Company hosted a retro-inspired Wellness House in Palm Springs during festival weekend, bringing together media, influencers, tastemakers and wellness enthusiasts for a celebration of Lifeway's legacy and continued role in shaping the modern wellness conversation.
  • The Company celebrated forty years of Kefir leadership with new cultured dairy innovations at Expo West 2026, showcasing its Lifeway Muscle Mates™ and Lifeway Kefir Butter™.

Outlook

The Company reiterated its long-term target of $45$50 million in Adjusted EBITDA1 for FY 2027 and believes it is well positioned to deliver the strongest annual sales in Company history in FY 2026.

"Our momentum continues to build as we drive sustainable, profitable growth across the business," Smolyansky concluded. "We have laid a foundation for durable, long-term value creation, and believe the investments we are making today in manufacturing capacity, marketing and innovation position us exceptionally well to capitalize on the tremendous opportunities ahead."

  1. Adjusted EBITDA is a non-GAAP financial measure. Adjusted EBITDA is defined as Operating Income, as reported, plus Depreciation and Amortization, plus Stock-Based Compensation.

Conference Call and Webcast
A webcast with Lifeway's President and Chief Executive Officer discussing these results with additional comments and details is available through the "Investor Relations" section of the Company's website at https://lifewaykefir.com/webinars-reports/.

About Lifeway Foods, Inc.
Lifeway Foods, Inc., which has been recognized as one of America's Growth Leaders by TIME, as Dairy Foods' Processor of the Year 2025, one of Forbes' Best Small Companies and named to Inc.'s 2025 Best in Business list in the Best Challenger Brands category, is America's leading supplier of the probiotic, fermented beverage known as kefir. In addition to its line of drinkable kefir, the Company also produces a variety of cheeses and a ProBugs® line for kids. Lifeway's tart and tangy fermented dairy products are now sold across the United States, Mexico, United Arab Emirates, Central America and the Caribbean. Learn how Lifeway is good for more than just you at lifewayfoods.com.

Forward-Looking Statements
This press release contains "forward-looking statements" as defined in the Private Securities Litigation Reform Act of 1995 regarding, among other things, unaudited estimated net sales. These statements use words, and variations of words, such as "anticipate," "plan," "project," "estimate," "potential," "forecast," "will," "continue," "future," "increase," "believe," "outlook," "expect," and "predict." You are cautioned not to rely on these forward-looking statements. These forward-looking statements are made as of the date of this press release, are based on current expectations of future events and thus are inherently subject to a number of risks and uncertainties, many of which involve factors or circumstances beyond Lifeway's control. If underlying assumptions prove inaccurate or known or unknown risks or uncertainties materialize, actual results could vary materially from Lifeway's expectations and projections. These risks, uncertainties, and other factors include: price competition; the decisions of customers or consumers; the actions of competitors; changes in the pricing of commodities; the effects of government regulation; possible delays in the introduction of new products; and customer acceptance of products and services. A further list and description of these risks, uncertainties, and other factors can be found in Lifeway's Annual Report on Form 10-K for the fiscal year ended December 31, 2025. Copies of these filings are available online at https://www.sec.govhttp://lifewaykefir.com/investor-relations/, or on request from Lifeway. Lifeway expressly disclaims any obligation to update any forward-looking statements (including, without limitation, to reflect changed assumptions, the occurrence of anticipated or unanticipated events or new information), except as required by law.

Non-GAAP Financial Measures
This press release refers to Adjusted EBITDA, which is a financial measure that has not been prepared in accordance with U.S. Generally Accepted Accounting Principles ("GAAP"), and may exclude items that are significant to understanding and assessing financial results. This non-GAAP measure is provided to enhance investors' overall understanding of the Company's financial performance. Non-GAAP financial measures should be considered as supplements to GAAP measures reported, should not be considered replacements for, or superior to, GAAP measures reported and may not be comparable to similarly named measures used by other companies. The Company's calculation of non-GAAP financial measures may differ from methods used by other companies.

We are unable to reconcile our target fiscal year 2027 Adjusted EBITDA to projected net income, the most directly comparable projected GAAP financial measure, because certain information necessary to calculate such measures on a GAAP basis is unavailable or dependent on the timing of future events outside of our control. Due to this uncertainty, the Company cannot reconcile target fiscal year 2027 Adjusted EBITDA to the nearest GAAP financial measure without unreasonable effort.

Derek Miller
Vice President of Communications, Lifeway Foods
Email: derekm@lifeway.net 

Perceptual Advisors
Dan Tarman
Email: dtarman@perceptualadvisors.com

General inquiries:
Lifeway Foods, Inc.
Phone: 847-967-1010
Email: info@lifeway.net

LIFEWAY FOODS, INC. AND SUBSIDIARIES
Unaudited Consolidated Balance Sheets
March 31, 2026 and December 31, 2025
(In thousands)




March 31, 2026


December 31,



(Unaudited)


2025

Current assets









Cash and cash equivalents


$

5,604



$

5,571


Accounts receivable, net of allowance for credit losses and discounts & allowances of $2,530
and $1,730 at March 31, 2026 and December 31, 2025, respectively



22,985




16,643


Inventories, net



11,452




11,890


Prepaid expenses and other current assets



2,588




2,627


Refundable income taxes



41




325


Total current assets



42,670




37,056











Property, plant and equipment, net



57,844




48,282


Operating lease right-of-use asset



553




465


Goodwill



11,704




11,704


Intangible assets, net



5,683




5,818


Other assets



2,051




2,285


Total assets


$

120,505



$

105,610











Current liabilities









Accounts payable


$

13,845



$

11,008


Accrued expenses



4,589




5,413


Accrued income taxes



1,518




218


Total current liabilities



19,952




16,639











Line of credit



6,939





Operating lease liabilities



426




360


Deferred income taxes, net



2,792




2,792


Other long-term liabilities



74





Total liabilities



30,183




19,791











Commitments and contingencies (Note 9)
















Stockholders' equity









Preferred stock, no par value; 2,500 shares authorized; none issued







Common stock, no par value; 40,000 shares authorized; 17,274 shares issued; 15,282 and
15,232 outstanding at March 31, 2026 and December 31, 2025, respectively



6,509




6,509


Treasury stock, at cost



(12,889)




(13,214)


Paid-in capital



3,347




3,843


Retained earnings



93,355




88,681


Total stockholders' equity



90,322




85,819











Total liabilities and stockholders' equity


$

120,505



$

105,610


 

LIFEWAY FOODS, INC. AND SUBSIDIARIES
Unaudited Consolidated Statements of Operations
For the three months ended March 31, 2026 and 2025
(In thousands, except per share data)




2026


2025






Net Sales


$

63,012



$

46,091











Cost of goods sold



44,741




34,254


Depreciation expense



920




802


Total cost of goods sold



45,661




35,056











Gross profit



17,351




11,035











Selling expense



6,188




4,698


General and administrative expense



4,703




4,628


Amortization expense



135




135


Total operating expenses



11,026




9,461











Income from operations



6,325




1,574











Other income (expense):









Interest expense



(68)




(14)


Gain on sales of investments






3,352


Other income (expense), net






54


Total other (expense) income



(68)




3,392











Income before provision for income taxes



6,257




4,966











Provision for income taxes



1,583




1,426











Net income


$

4,674



$

3,540











Net earnings per common share:









Basic


$

0.31



$

0.23


Diluted


$

0.30



$

0.23











Weighted average common shares outstanding:









Basic



15,257




15,134


Diluted



15,559




15,333


 

LIFEWAY FOODS, INC. AND SUBSIDIARIES
Consolidated Statements of Cash Flows
(Unaudited)
(In thousands)




Three months ended March 31,



2026


2025

Cash flows from operating activities:









Net income


$

4,674



$

3,540


Adjustments to reconcile net income to operating cash flow:









Depreciation and amortization



1,055




937


Stock-based compensation



548




326


Non-cash interest expense



5




3


Bad debt expense



87





Gain on sale of investments






(3,352)


Fair value loss on investment






20


(Increase) decrease in operating assets:









Accounts receivable



(6,429)




(1,259)


Inventories



438




(563)


Prepaid expenses and other current assets



228




136


Refundable income taxes



283




631


Increase (decrease) in operating liabilities:









Accounts payable



3,397




1,401


Accrued expenses



(1,282)




(2,765)


Accrued income taxes



1,300




795


Other long-term liabilities



74





Net cash provided by (used in) operating activities



4,378




(150)











Cash flows from investing activities:









Purchases of property and equipment



(11,041)




(2,219)


Proceeds from sale of investments






5,152


Net cash (used in) provided by investing activities



(11,041)




2,933











Cash flows from financing activities:









Borrowings under line of credit



8,000





Repayments under line of credit



(1,000)





Payment of deferred financing costs



(21)




(65)


Equity award settled in cash



(283)





Net cash provided by (used in) financing activities



6,696




(65)











Net increase in cash and cash equivalents



33




2,718











Cash and cash equivalents at the beginning of the period



5,571




16,728











Cash and cash equivalents at the end of the period


$

5,604



$

19,446











Supplemental cash flow information:









Cash paid for income taxes, net of (refunds)


$



$


Cash paid for interest


$

45



$

11











Non-cash investing activities









Accrued purchase of property and equipment


$

216



$

239


Right-of-use assets obtained in exchange for lease obligations


$

119



$

8


 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/lifeway-foods-announces-record-breaking-results-for-the-first-quarter-ended-march-31-2026-302771741.html

SOURCE Lifeway Foods, Inc.

FAQ

What were Lifeway Foods (LWAY) Q1 2026 net sales and growth rate?

Lifeway Foods reported Q1 2026 net sales of $63.0 million, a 36.7% year-over-year increase. According to Lifeway, this surpassed sixty million in quarterly net sales for the first time and marked its 26th consecutive quarter of year-over-year net sales growth.

How did Lifeway Foods (LWAY) Q1 2026 profitability and margins change?

Lifeway Foods posted Q1 2026 net income of $4.7 million, up 32% year-over-year. According to Lifeway, gross profit margin improved to 27.5%, a 360-basis-point increase from 23.9% last year, reflecting the impact of higher net sales and operational execution.

What were Lifeway Foods (LWAY) Q1 2026 SG&A expenses and investment focus?

Lifeway Foods reported Q1 2026 SG&A expenses of $10.9 million, up 16.8% year-over-year. According to Lifeway, this increase reflects continued investment in marketing and brand awareness, while SG&A as a percentage of sales was leveraged by 300 basis points in the quarter.

What long-term Adjusted EBITDA target has Lifeway Foods (LWAY) reiterated?

Lifeway Foods reiterated a long-term Adjusted EBITDA target of $45–$50 million for FY 2027. According to Lifeway, Adjusted EBITDA is defined as operating income plus depreciation and amortization plus stock-based compensation, and the company believes it remains well positioned to meet this target.

How is Lifeway Foods (LWAY) driving product and brand growth in 2026?

Lifeway Foods is emphasizing Kefir and Farmer Cheese growth, alongside innovations like Muscle Mates and Kefir Butter. According to Lifeway, partnerships with Erewhon, a Palm Springs Wellness House activation, and Expo West 2026 product showcases aim to expand brand visibility and consumer reach.

What outlook did Lifeway Foods (LWAY) provide for FY 2026 sales performance?

Lifeway Foods believes it is well positioned to deliver the strongest annual sales in its history in FY 2026. According to Lifeway, momentum in protein-rich, probiotic foods and ongoing investments in manufacturing capacity, marketing, and innovation support this sales outlook.